nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
ADME/PK as part of a rational approach to drug discovery
|
Eddershaw, Peter J |
|
2000 |
5 |
9 |
p. 409-414 6 p. |
artikel |
2 |
A new target for HIV-1 entry inhibition?
|
Lawrence, Rebecca N |
|
2000 |
5 |
9 |
p. 380-381 2 p. |
artikel |
3 |
Building relationships between academia and the pharmaceutical industry
|
Dean, Philip |
|
2000 |
5 |
9 |
p. 377-378 2 p. |
artikel |
4 |
Combinatorial chemistry
|
Edwards, Paul |
|
2000 |
5 |
9 |
p. 431-432 2 p. |
artikel |
5 |
Contribution of NO/ONOO− pathway to the deleterious effect of traumatic brain injury in mice
|
Mésenge, Christian |
|
2000 |
5 |
9 |
p. 432-433 2 p. |
artikel |
6 |
Gender-specific responses reveal untapped potential of κ-opioids
|
Senior, Kathryn |
|
2000 |
5 |
9 |
p. 383-384 2 p. |
artikel |
7 |
Identification and in vivo efficacy of small-molecule antagonists of integrin αvβ3 (the vitronectin receptor)
|
Miller, William H |
|
2000 |
5 |
9 |
p. 397-408 12 p. |
artikel |
8 |
Making drug discovery a SN(i)P
|
Campbell, David A |
|
2000 |
5 |
9 |
p. 388-396 9 p. |
artikel |
9 |
Monitor: molecules and profiles
|
Lloyd, Andrew W |
|
2000 |
5 |
9 |
p. 427-429 3 p. |
artikel |
10 |
News in brief
|
Lawrence, Rebecca N |
|
2000 |
5 |
9 |
p. 385-387 3 p. |
artikel |
11 |
Novel drug development strategy targets protein ‘export’
|
Senior, Kathryn |
|
2000 |
5 |
9 |
p. 379-380 2 p. |
artikel |
12 |
Pharmacogenomics
|
Lloyd, Andrew |
|
2000 |
5 |
9 |
p. 429-430 2 p. |
artikel |
13 |
Serial analysis of gene expression: from gene discovery to target identification
|
Madden, Stephen L |
|
2000 |
5 |
9 |
p. 415-425 11 p. |
artikel |
14 |
Signalling in Huntington’s disease: novel targets identified
|
Fricker, Janet |
|
2000 |
5 |
9 |
p. 381-382 2 p. |
artikel |
15 |
Virtual drug resistance testing in HIV
|
Dorrell, Sharon |
|
2000 |
5 |
9 |
p. 384-385 2 p. |
artikel |